Coronavirus

About Coronavirus

As California’s hospitals continue their life-saving work during the COVID-19 pandemic, the hospital associations continue to advocate on behalf of hospitals and their patients, in addition to offering these tools and resources:

Streamlining data with the COVID-19 Tracking Tool
Frequently asked questions
COVID-19 Surges: FAQs & Resources for Hospitals
State and federal advocacy efforts
Innovation in the Time of COVID: A Video Series

CDPH Issues FAQs on Visitation Health Order

On Aug. 20, CDPH issued FAQs on the state public health officer order on hospital visitation. This health order requires vaccine verification or proof of a COVID-19 test for visitors of hospitals and other facilities. The FAQs provide clarifications, in addition to those issued in All Facilities Letter (AFL) 21-31, on who is covered by […]

FDA Announces Approval of Pfizer-BioNTech COVID-19 Vaccine

The Food and Drug Administration (FDA) today announced its full approval for the Pfizer-BioNTech COVID-19 vaccine — under the name Comirnaty — for individuals 16 and older, making it the first COVID-19 vaccine to go beyond emergency use authorization (EUA) in the U.S. 

CDPH Issues FAQs on Visitation Health Order

On Aug. 20, CDPH issued FAQs on the state public health officer order on hospital visitation. This health order requires vaccine verification or proof of a COVID-19 test for visitors of hospitals and other facilities. The FAQs provide clarifications, in addition to those issued in All Facilities Letter (AFL) 21-31, on who is covered by the order and who is […]

FDA Announces Approval of Pfizer-BioNTech COVID-19 Vaccine

The Food and Drug Administration (FDA) today announced its full approval for the Pfizer-BioNTech COVID-19 vaccine — under the name Comirnaty — for individuals 16 and older, making it the first COVID-19 vaccine to go beyond emergency use authorization (EUA) in the U.S.  

Additional mRNA Vaccine Dose Authorized for ‘Moderately to Severely Immunocompromised’ Individuals

On Aug. 12, the Food and Drug Administration (FDA) expanded the emergency use authorization (EUA) for both the Pfizer-BioNTech and Moderna mRNA COVID-19 vaccines to allow for the use of an additional dose in certain immunocompromised individuals ages 12 and older. Following that announcement, the Centers for Disease Control and Prevention issued a recommendation that […]

CDC Announces COVID-19 Vaccine Boosters for All, CMS Updates Coding Guidance

The Centers for Disease Control and Prevention (CDC) announced plans to begin offering COVID-19 booster shots to all individuals beginning the week of Sept. 20 and starting eight months after an individual’s second dose, pending authorization from the Food and Drug Administration (FDA) and a review by the CDC’s vaccine advisory committee.